SEC Form 4 · accession 0001178913-26-003106
MediWound Ltd. · MDWD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nachum Shamir
Director
Period of report
Jun 3, 2026
Accepted (ET)
Jun 4, 2026 · 4:05 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001593984
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Jun 3, 2026 | P | 175 | $13.975 | A | 49,990 | D | |
| Ordinary Shares | Jun 3, 2026 | P | 5,825 | $14.00 | A | 55,815 | D | |
| Ordinary sharesF1,F2 | holding | — | — | — | 1,200 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A Warrants | $13.475 | holding | — | — | — | Nov 28, 2022 | Nov 28, 2026 | Ordinary Shares | 16,336 | 16,336 | D |
| Stock Option (right to buy ordinary shares)F2 | $12.495 | holding | — | — | — | Aug 17, 2023 | Aug 17, 2032 | Ordinary Shares | 28,571 | 28,571 | D |
| Stock Option (right to buy ordinary shares)F2 | $11.885 | holding | — | — | — | May 31, 2024 | May 30, 2033 | Ordinary Shares | 11,800 | 11,800 | D |
| Stock Option (right to buy ordinary shares)F2 | $12.729 | holding | — | — | — | Feb 26, 2025 | Feb 26, 2034 | Ordinary Shares | 12,570 | 12,570 | D |
| Stock Option (right to buy ordinary shares)F2 | $18.54 | holding | — | — | — | Feb 11, 2026 | Feb 11, 2035 | Ordinary Shares | 9,200 | 9,200 | D |
| Stock Option (right to buy ordinary shares)F2,F3 | $17.60 | holding | — | — | — | — | Mar 4, 2036 | Ordinary Shares | 10,000 | 10,000 | D |
Explanation of responses
- F1The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date.
- F2There were no transactions affected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
- F3The options reported in this row were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date.
Remarks
Exhibit 24.1 - Power of Attorney